Your session is about to expire
← Back to Search
Single Psilocybin Treatment for Major Depressive Disorder
Study Summary
"This trial aims to test how effective psilocybin-assisted therapy is in treating depression. Participants will undergo screening, receive psilocybin treatment, and attend follow-up sessions over a year.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 2 trial • 56 Patients • NCT00465595Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the specific objectives of this research study?
"The primary objective of this investigation, conducted over a span of 2 weeks starting from the baseline assessment, is to assess alterations in QIDS SR-16 scores between the initial evaluation and 2 weeks post-treatment. Secondary endpoints comprise changes in HAM-D-17 ratings between the commencement and 6 weeks after treatment. This involves evaluating modifications in HAM-D-17 scores between baseline and two weeks following intervention. The HAM-D-17 questionnaire consists of 17 items designed to gauge depression severity, with total scores ranging from 0 to 52; higher values suggest heightened depression levels. Additionally, secondary outcomes include determining the number"
What is the safety profile of a single dose psilocybin treatment for individuals?
"The safety rating for Single Psilocybin Treatment is deemed as 3 by our team at Power, aligning with the Phase 3 trial status. This indicates existing efficacy data and robust safety evidence from multiple assessments."
Is the trial open to individuals older than 40 years of age?
"To be eligible for this research endeavor, individuals aged between 18 and 70 are encouraged to apply. Notably, there are a total of 227 trials catering to those under the age of majority and 1033 aimed at the elderly population above 65 years old."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger